Stay updated on Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed. This appears to be a behind-the-scenes update with no impact on study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-01-14T02:43:15.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The Locations section was updated to add new study sites across the US, France, Japan, Russia, Spain, and the UK, and the revision version was updated to v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T13:31:19.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2 is shown on the page. This is a minor internal update that does not affect study content or user-facing information, and To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:45:56.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Publications section now states that entries are automatically filled from PubMed and may not all pertain to the study. Revision updated from v3.2.0 to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T14:49:35.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Removed a funding-status disclaimer indicating potential delays due to government funding lapse; the page no longer displays operating status notes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T07:11:50.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The screenshots show the same study page with identical core content including Study Overview, eligibility criteria, and locations; no substantive data or status changes are present. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:23:23.000Z thumbnail image

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.